[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid] NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]

Hautarzt. 1997 Apr;48(4):262-5. Unique Identifier : AIDSLINE MED/97295475
Waldmann V; Kempf W; Burg G; Dummer R; Dermatologische Klinik, Universitatsspital Zurich.

Abstract: A 76 year old patient with actinic reticuloid was treated with Cyclosporin A. 11 months after beginning the immunosuppressive therapy, he developed lymphoedema and livid nodular skin lesions of the right leg, which histologically showed Kaposi's sarcoma. After stopping the Cyclosporin A and intralesional therapy with Interferon alpha, no regression of the Kaposi sarcoma could be seen. The characteristics of Kaposi sarcoma arising during immunosuppressive therapy and the differences in incidence, risk groups and distribution pattern compared to the classic sporadic and the AIDS-related Kaposi sarcoma will be described. The development of Kaposi sarcoma during immunosuppressive therapy for actinic reticuloid has not been previously described.
Keywords: *Cyclosporine/ADVERSE EFFECTS *Immunosuppressive Agents/ADVERSE EFFECTS *Photosensitivity Disorders/DRUG THERAPY *Sarcoma, Kaposi's/CHEMICALLY INDUCED *Skin Neoplasms/CHEMICALLY INDUCEDKWDcyclosporine/adverseeffectsKWDimmunosuppressiveagents/adverseeffectsKWDphotosensitivitydisorders/drugtherapyKWDsarcoma,kaposi's/chemicallyinducedKWDskinneoplasms/chemicallyinduced
970930
M9791348

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .